Kevin Benny
About Kevin Benny
Kevin Benny is the Associate Director of Commercialization Analytics for US Hematology (Reblozyl) at Bristol Myers Squibb, with extensive experience in research and analytics across various organizations.
Company
Kevin Benny is currently employed at Bristol Myers Squibb, where he serves as the Associate Director of Commercialization Analytics for US Hematology (Reblozyl). Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.
Title
Kevin Benny holds the title of Associate Director, Commercialization Analytics, US Hematology (Reblozyl) at Bristol Myers Squibb. In this role, he provides critical analytics and insights to support the commercialization of Reblozyl, a therapeutic that targets hematological conditions.
Education and Expertise
Kevin Benny earned a Bachelor of Science (BS) in International Business from The College of New Jersey, where he also completed an undergraduate thesis. Additionally, he has studied Statistics in Medicine at Stanford University. His expertise includes both qualitative and quantitative research methodologies, and he is passionate about using data to tell compelling stories and drive actionable insights.
Background
Kevin Benny has a diverse professional background. He began his career as a Classroom Aide at the Emerson Board of Education, followed by teaching mathematics at both Middletown High School North and Red Bank Regional High School. He transitioned into market research roles where he worked for SKIM, Branding Science, and MyHealthTeam. His positions at these companies included Market Research Analyst, Senior Research Executive, Research Manager, and Senior Manager of Research. He later joined Bristol Myers Squibb as Senior Manager, Hematology Customer & Market Insights before advancing to his current role.